IGM Biosciences, Inc. Rings the Opening Bell in Celebration of its IPO

Date & Time Sep 18, 2019 9:00am - 9:45am
Location Nasdaq MarketSite, 4 Times Square New York


IGM Biosciences, Inc. (Nasdaq: IGMS), a biotechnology company focused on creating and developing engineered IgM antibodies for the treatment of cancer patients, visited the Nasdaq MarketSite in Times Square.

In honor of the occasion, the below members of the IGM team rang the Opening Bell:

  • Fred Schwarzer, Chief Executive Officer
  • Bruce Keyt, Chief Scientific Officer
  • Jakob Topsøe, Director
  • Christina Topsøe, Director
  • Nelson Teng, Scientific Founder

Nasdaq Watch

See what's playing at Nasdaq

Watch Now